Hidden virus linked to hip bone collapse, offering hope for true prevention of osteonecrosis

Osteonecrosis of the femoral head is a devastating bone disease that often strikes without warning, progresses silently, and frequently ends in total hip replacement. Although steroid use, alcohol exposure and trauma are recognized risk factors, many cases remain unexplained, and individuals with similar exposures can have dramatically different outcomes. For decades, clinicians have suspected that an unseen biological factor determines who develops hip collapse — but evidence has been lacking.

A new clinical study from researchers at Nanjing University and Jiangsu Province Hospital now identifies a surprising candidate: localized reactivation of human cytomegalovirus (HCMV) inside the femoral head. The findings, published in the Journal of Bone and Mineral Research, suggest that a common latent virus carried harmlessly by most adults worldwide may act as a hidden amplifier of microvascular injury leading to bone death.

Human cytomegalovirus is a lifelong latent herpesvirus present in more than 60% of the global population. In healthy individuals it rarely causes overt illness, remaining under tight immune control. However, it can periodically reactivate, especially under inflammatory or immunomodulatory conditions. The new study demonstrates that such reactivation can occur locally inside bone tissue, without detectable virus in the bloodstream.

The research team examined femoral-head specimens from patients undergoing surgery for osteonecrosis. Viral DNA and viral protein expression were found predominantly in necrotic and transitional regions of the femoral head, particularly within damaged microvessels. Importantly, the degree of viral reactivation closely correlated with lesion volume and disease severity.

“These results suggest that local viral reactivation may be an unrecognized biological factor contributing to osteonecrosis progression,” said Lei Dong, PhD, senior author of the study. “It provides a potential explanation for why some patients develop femoral-head collapse after modest risk exposure, while others do not.”

A finding that fits long-standing clinical puzzles

Osteonecrosis is widely believed to begin with disruption of blood supply to the femoral head. Yet the trigger for this microvascular failure has remained uncertain, particularly in so-called idiopathic cases.

HCMV is known to infect vascular endothelial cells and to promote local inflammation, vascular dysfunction and tissue edema. The femoral head, enclosed in rigid bone with limited capacity to accommodate swelling, is especially vulnerable to repeated microvascular insults. Localized viral reactivation therefore offers a biologically plausible mechanism linking inflammation, vascular injury and eventual bone necrosis.

Notably, viral activity was detected only in femoral-head tissue and not in peripheral blood, explaining why systemic viral testing has never revealed an association in previous studies.

An accompanying editorial in the same journal describes the discovery as adding “another crime to the cytomegalovirus crime sheet,” highlighting that HCMV can cause highly tissue-specific pathology even in patients without systemic viral reactivation.

From “idiopathic” to potentially preventable

Up to half of osteonecrosis cases are currently labeled idiopathic, meaning no identifiable cause. The present findings suggest that many of these cases may instead involve silent viral reactivation within bone.

If future longitudinal and mechanistic studies confirm a causal role, the implications could be significant:

Risk stratification: identifying patients susceptible to viral reactivation before irreversible damage occurs

Early intervention: monitoring viral or immune markers during steroid therapy or other high-risk settings

True prevention: evaluating antiviral or immune-modulating strategies to block disease progression

Such approaches have transformed clinical management of HCMV in transplant medicine, and similar strategies could become possible for osteonecrosis.

Next steps

The authors emphasize that the current study establishes a strong clinical association but does not yet prove causality. Ongoing work will focus on prospective patient monitoring, experimental models, and evaluation of antiviral interventions.

Nevertheless, experts note that the discovery provides a clear and testable roadmap for future research into a disease that has long lacked mechanistic clarity.

Publication

Research article:

Osteonecrosis of the femoral head is associated with cytomegalovirus reactivation

Journal of Bone and Mineral Research — January 6, 2026

DOI: 10.1093/jbmr/zjaf205

Editorial:

Adding to the cytomegalovirus crime sheet?

Journal of Bone and Mineral Research — January 2026

Doi: 10.1093/jbmr/zjag016